EPA to release findings on flea and tick products
Washington D.C. -- The EPA will discuss its findings from a five-year study of flea and tick products Wednesday during a free, public Webinar, titled "Evaluation of Pet Spot-on Flea and Tick Products and Next Steps."
Washington D.C.
-- The EPA will discuss its findings from a five-year study of flea and tick products Wednesday during a free, public Webinar, titled “Evaluation of Pet Spot-on Flea and Tick Products and Next Steps.”
The agency will present an overview of its evaluation of the products and its plans to further protect pets. Participants will have the opportunity to submit questions, which EPA presenters will address as time allows.
The EPA announced last April that it would increase the scrutiny of flea and tick products after an increased rate in the number of adverse effects.
For more information or to register for the Webinar, click here.
FDA approves oral drug for broad canine protection against parasites
October 7th 2024Elanco's lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets (Credelio Quattro) provide a single monthly dose for protection against fleas, ticks, heartworms, roundworms, hookworms, and 3 species of tapeworm.
Read More
dvm360 announces winners of the Veterinary Heroes program
Published: September 6th 2024 | Updated: November 5th 2024This year’s event is supported by corporate sponsor Schwarzman Animal Medical Center and category sponsors Blue Buffalo Natural, MedVet, Banfield Pet Hospital, Thrive Pet Healthcare and PRN Pharmacal.
Read More
